Dietary supplements containing L-ornithine L-aspartate (LOLA) are on the rise. Thus, a simple, reliable method of analysis for determining LOLA has been developed, which helps to control product quality. In this study, a method for determining LOLA in dietary supplements by HPLC in combination with o-phtalaldehyde derivatives (OPA) was developed and validated. The study optimized conditions for extraction of LOLA from the matrix, then derived with OPA and chromatographic separation on column C18. The detection limits and quantitative limits of the method were conducted on low-content real samples, with LOD and LOQ values achieved at 6.0 and 20.0 μg/g, respectively. The method has good recovery (98 – 106%) and repeatability (1.32 – 3.50%) that meet the method performance requirements according to AOAC. The validated method has been applied to analyze LOLA content in dietary supplements at the National Institute for Food Control.
L-ornithine L-aspartate, health food supplement, HPLC, amino acids, precolumn derivatization, o-phthalaldehyde, OPA.
[1]. National Center for Biotechnology Information. PubChem Compound Summary for CID 10220941, L-Ornithine L-aspartate.
[2]. S. Demura, T. Yamada, S. Yamaji, M. Komatsu, and K. Morishita, "The effect of Lornithine hydrochloride ingestion on performance during incremental exhaustive ergometer bicycle exercise and ammonia metabolism during and after exercise," European Journal of Clinical Nutrition, vol. 64, no. 10, pp. 1166-71, 2010.
[3]. M. M. Di Fiore, C. Lamanna, L. Assisi, and V. Botte, "Opposing effects of D-aspartic acid and nitric oxide on tuning of testosterone production in mallard testis during the reproductive cycle," Reproductive Biology and Endocrinology, vol. 6, p. 28, 2008.
[4]. G. Kircheis and S. Luth, "Pharmacokinetic and Pharmacodynamic Properties of LOrnithine L-Aspartate (LOLA) in Hepatic Encephalopathy," Drugs, vol. 79, no. Suppl 1, pp. 23-29, 2019.
[5]. P. Kowalski, M. Bieniecki, I. Oledzka, and H. Lamparczyk, "Validated method for Lornithine-L-aspartate analysis in human plasma by capillary electrophoresis," Biomedical Chromatography, vol. 20, no. 2, pp. 185-94, 2006.
[6]. Yuan Haoyu Yu Yu, Zeng Jianpeng., "Determination of L-Ornithine-L-Asparate by HPLC," Drug Information, vol. 05, no. 04, pp. 62-66, 2016.
[7]. L.G. Berwald R.C. Dorresteijn, G. Zomer, C.D. de Gooijer, G. Wieten, E.C. Beuvery,, "Determination of amino acids using o-phthalaldehyde-2-mercaptoethanol derivatization effect of reaction conditions," Journal of Chromatography A, vol. 724, no. 1-2, pp. 159-167, 1996.
[8]. Catherine A. Cooper, Nicolle H. Packer, and Keith Leslie Williams, "Amino acid analysis protocols," Semantic Scholar, 2000.
[9]. Mohan Seelam, Bhavani Podili, and Prasada Rao Kammela, "A Validated specific Stability-Indicating Reversed-Phase High-Performance Liquid Chromatography Assay Method for L-Ornithine L-Aspartate and Silymarin, and their related Substances and its Application to Dissolution Studies," International Journal of Pharmaceutical Quality Assurance, vol. 11, no. 03, pp. 317-328, 2020.
[10]. Shigeyuki Oguri, "Quantitation of Amino Acids as o-Phthalaldehyde Derivatives by CE," Journal of Chromatography Library, vol. 70, pp. 297-308, 2005.
[11]. Nikhat G. Sheikh, Vijay M. Tangde, Sudhakar S. Dhondge, Alka S. Dhondge, and Niraj T. Khaty, "Investigation of the effect of temperature on aggregation behaviour and thermodynamic properties of Ornithine monohydrochloride in aqueous and aqueous dextrose and urea solutions," The Journal of Chemical Thermodynamics, vol. 151, 2020.
[12]. George W. Latimer, "Appendix F Guidelines for Standard Method Performance Requirements," AOAC International, 2023.